Company: PFSA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004396
Chunk: 639

Company: Profusa, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 3
Chunk 639
---
ITEM 3. LEGAL PROCEEDINGS 

To the knowledge of our management, there is no
litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of
our property. 

ITEM 4. MINE SAFETY DISCLOSURE 

Not applicable.

40

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our units commenced public
trading on December 20, 2021, under the symbol “NVACU”. Our shares of common stock, rights, and warrants began separate trading
on January 21, 2022, under the symbols “NVAC,” “NVACR,” and “NVACW” respectively, and our units ceased
trading on such separation date. On December 27, 2024, the common stock, rights, and warrants began to be quoted on the OTC Pink
Sheets under the same symbols.

Holders 

As of March 28, 2025, there
were four holders of record for our shares common stock, one holder of record of our rights, and five holders of record of our warrants. 

Dividends

We have not paid any cash
dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The payment
of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of a business combination. The payment of any cash dividends subsequent to a business combination will be within
the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not
anticipate declaring any stock dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends
may be limited by restrictive covenants we may agree to in connection therewith. 

Recent Sales of Unregistered Securities; Use of Proceeds from Registered
Offering

On December 22, 2021, we consummated
our initial public offering (“IPO”) of 18,975,000 units, including the issuance of 2,475,000 units as a result of the underwriters’
exercise of their over-allotment option in